These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2970240)
1. ["Crocodile baby", a non-fatal form of malignant keratoma?]. Masouyé I; Harms M; Saurat JH Ann Dermatol Venereol; 1988; 115(3):311-5. PubMed ID: 2970240 [No Abstract] [Full Text] [Related]
2. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma. Tamayo L; Ruiz-Maldonado R Dermatologica; 1980; 161(5):305-14. PubMed ID: 6449393 [TBL] [Abstract][Full Text] [Related]
3. [Congenital erythrodermal states in childhood]. Levi L; Caputo R G Ital Dermatol Minerva Dermatol; 1968; 109(4):229-44. PubMed ID: 4240024 [No Abstract] [Full Text] [Related]
4. Retinoids in disorders of keratinization: their use in adults. Happle R; van de Kerkhof PC; Traupe H Dermatologica; 1987; 175 Suppl 1():107-24. PubMed ID: 2961628 [TBL] [Abstract][Full Text] [Related]
6. Transepidermal water loss and sweat gland response in lamellar ichthyosis before and during treatment with etretinate: report of three cases. Kiistala R; Lauharanta J; Kanerva L Acta Derm Venereol; 1982; 62(3):268-70. PubMed ID: 6179379 [No Abstract] [Full Text] [Related]
7. Pilot study of a new retinoid, Ro 12-7554, in psoriasis and in some congenital disorders of keratinization. Ott F; Bounameaux Y Dermatologica; 1983; 167(1):52-3. PubMed ID: 6226548 [TBL] [Abstract][Full Text] [Related]
8. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason). Jagell S; Lidén S Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505 [TBL] [Abstract][Full Text] [Related]
9. Acitretin in the symptomatic therapy for severe recessive x-linked ichthyosis. Bruckner-Tuderman L; Sigg C; Geiger JM; Gilardi S Arch Dermatol; 1988 Apr; 124(4):529-32. PubMed ID: 2965549 [TBL] [Abstract][Full Text] [Related]
11. [Progressive symmetric erythrokeratodermia. Report of a case with delayed onset treated by etretinate]. Borbujo Martinez J; Casado Jimenez M; Jimenez Acosta F; Almagro Sanchez M; Martinez Gomez W; Soto Melo J Med Cutan Ibero Lat Am; 1988; 16(3):236-8. PubMed ID: 2974108 [TBL] [Abstract][Full Text] [Related]
12. Etretinate (Tigason) for skin disease. Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967 [No Abstract] [Full Text] [Related]
13. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal. Findlay GH S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876 [TBL] [Abstract][Full Text] [Related]
14. Is the use of Ro 10-9359 (Tigason) in children justified? van der Rhee HJ; van Gelderen HH; Polano MK Acta Derm Venereol; 1980; 60(3):274-5. PubMed ID: 6158237 [TBL] [Abstract][Full Text] [Related]
15. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418 [TBL] [Abstract][Full Text] [Related]
16. [Mendes Da Costa erythrokeratoderma variabilis. Effect of RO 10-9359 (Tigason)]. Larrègue M; Bressieux JM; Titi A; De Voel G; Bieder C; Lhuillier N; Bachour I Ann Dermatol Venereol; 1988; 115(11):1123-5. PubMed ID: 2977072 [No Abstract] [Full Text] [Related]